website statistics

Aviva Systems Biology

Account Login 

Aviva Systems Biology office will be closed on Memorial Day - 5/27/2013.
Please go here for more info.

Now Offering Over 48,216 Antibodies & 21,887 Antigens!

Print Page
1mg
$520.00
In Stock

MAb to Glyceraldehyde-3-PDH Antibody (1mg)

Aviva Systems Biology is a leading manufacturer of antibodies, proteins, peptides, and accessory reagents. Aviva’s catalog is filled with many unique products. If you need assistance at any time in your searches, please email us at info@avivasysbio.com.

Aviva has generated over 5,000 product categories to assist you when browsing our catalog. Please select the related products tab below to view other relevant reagents.

Please review the product specifications below.
Gene Symbol:
GAPDH
Alias Symbols:
Monoclonal Antibody to Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH)
Tissue Tool:
Find tissues and cell lines supported to express GAPDH.
Full Name:
Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH)
Protein Accession# :
NP_002037.2
Swissprot Id:
P04406
Host:
Mouse. Hybridization of Sp2/0 myeloma cells with spleen cells from BALB/c mice. --- Source: Ascites
Specificity:
Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH)
Cross-reacts with GAPDH from Human, bovine, porcine, goat, rabbit and rat.
Application:
ELISA, ICC, IA, WB
Clone:
B903M
Product Format:
Purified, Liquid
Purity:
>90% pure (SDS-PAGE). Protein A chromatography
Isotype:
IgG1
:::
Buffer: PBS, pH 7.4

Preservative: 0.1% Sodium azide

Important Note: Centrifuge before opening to ensure complete recovery of vial contents.

Warnings: This product contains sodium azide, which has been classified as Xn (Harmful), in European Directive 67/548/EEC in the concentration range of 0.1 - 1.0 %. When disposing of this reagent through lead or copper plumbing, flush with copious volumes
Reconstitution and Storage:
Store at 2 to 8C.
Datasheets / Downloads:
OAMA01120
Application Data:
Immunogen: Human or rabbit GAPDH

Affinity Constant: Not determined

Product Protocols: Immunoblotting Protocol with MAb to Glyceraldehyde-3-PDH Antibody (1mg) Antibody (Catalog Number: OAMA01120)

Product Protocols:
Immunoblotting Protocol with Gene Name: MAb to Glyceraldehyde-3-PDH Antibody (1mg) Antibody (Catalog Number: OAMA01120)

Catalog Number: OAMA01120

Reference:
1: Wils H, Kleinberger G, Janssens J, Pereson S, Joris G, Cuijt I, Smits V, Ceuterick-de Groote C, Van Broeckhoven C, Kumar-Singh S.TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration.Proc Natl Acad Sci U S A.2010 Feb 23;107(8):3858-63.Epub 2010 Feb 3.PubMed PMID: 20133711; PubMed Central PMCID: PMC2840518.

Product Name: MAb to Glyceraldehyde-3-PDH Antibody (1mg)

MAb to Glyceraldehyde-3-PDH Antibody (1mg)

Species: Human

Sample description: Has both glyceraldehyde-3-phosphate dehydrogenase and nitrosylase activities, thereby playing a role in glycolysis and nuclear functions, respectively.Participates in nuclear events including transcription, RNA transport, DNA replication and apoptosis.Nuclear functions are probably due to the nitrosylase activity that mediates cysteine S-nitrosylation of nuclear target proteins such as SIRT1, HDAC2 and PRKDC By similarity.Glyceraldehyde-3-phosphate dehydrogenase is a key enzyme in glycolysis that catalyzes the first step of the pathway by converting D-glyceraldehyde 3-phosphate (G3P) into 3-phospho-D-glyceroyl phosphate.

Experiment Name: Immunoblotting

Experiment Background:
Frozen tissue was weighed and homogenized in buffer containing 10 mM Hepes, 10 mM NaCl, 1 mM KH2PO4, 5 mM NaHCO3, 5 mM EDTA, 1 mM CaCl2, 0.5 mM MgCl2 (10× vol/wt).
2.After 10 min on ice, 2.5 M sucrose (0.5× vol/wt) was added.
3.Next, tissue was homogenized and centrifuged at 6,300 × g for 10 min.
4.The supernatant was collected as cytoplasmic fraction.
5.The pellet was washed three times in TSE buffer (10 mM Tris, 300 mM sucrose, 1 mM EDTA, 0.1% Nonidet P-40, 10× vol/wt), homogenized, and centrifuged at 4,000 × g for 5 min.
6.Finally the pellet was resuspended in RIPA with 2% SDS (5× vol/wt) as the nuclear fraction.
7.Also, proteins were sequentially extracted with buffers of increasing detergent strength (hypotonic, Triton X-100, myelin floatation, sarkosyl, and urea buffers).
8.All buffers were substituted with protease inhibitors (Complete Mixture; Roche) and phosphatase inhibitors (PhosphoStop; Roche) before use.
9.The following antibodies were used: rabbit anti-TDP-43 (ProteinTech Group), human specific mouse anti-TDP-43 (against residues 205-222; Abnova), rabbit anti-C-terminal TDP-43 (C-t TDPFig 43), rabbit anti-TDP-43 phosphorylation sites 409/410 (TDP-43 p409/410), rabbit anti-cleaved caspase-3, and rabbit anti-cleaved PARP (Cell Signaling Technology).
10.Detection was performed using HRP-conjugated secondary antibodies and ECL Plus Chemiluminescent Detection System (Amersham Biosciences).
1 Data were normalized to beta -actin (Sigma), GAPDH (Meridian Life Science), or Lamin A/C (N-18; Santa Cruz Biotechnology).
Experiment step:
Data were normalized to beta -actin (Sigma), GAPDH (Meridian Life Science), or Lamin A/C (N-18; Santa Cruz Biotechnology).